CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 120 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $156,331 | +40.8% | 26,769 | +20.4% | 0.00% | – |
| Q1 2021 | $111,000 | -87.5% | 22,225 | -68.3% | 0.00% | -100.0% |
| Q4 2020 | $885,000 | +25.0% | 70,014 | -2.9% | 0.00% | +33.3% |
| Q3 2020 | $708,000 | -2.3% | 72,114 | -1.1% | 0.00% | -25.0% |
| Q2 2020 | $725,000 | -2.9% | 72,914 | -13.7% | 0.00% | -20.0% |
| Q1 2020 | $747,000 | -7.5% | 84,501 | -3.6% | 0.01% | +66.7% |
| Q4 2019 | $808,000 | +56.0% | 87,614 | -0.6% | 0.00% | +50.0% |
| Q3 2019 | $518,000 | -73.2% | 88,114 | -45.3% | 0.00% | -71.4% |
| Q2 2019 | $1,934,000 | -2.8% | 161,134 | -2.2% | 0.01% | -12.5% |
| Q1 2019 | $1,990,000 | -4.8% | 164,834 | -1.0% | 0.01% | -11.1% |
| Q4 2018 | $2,090,000 | -53.8% | 166,525 | -45.4% | 0.01% | -47.1% |
| Q3 2018 | $4,523,000 | -17.7% | 304,755 | -6.7% | 0.02% | -26.1% |
| Q2 2018 | $5,496,000 | -30.6% | 326,555 | -5.5% | 0.02% | -36.1% |
| Q1 2018 | $7,915,000 | – | 345,625 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |